Optinose gets FDA nod for Xhance in chronic rhinosinusitis without nasal polyps
Xhance is a drug-device combination product that utilises the Exhalation Delivery System engineered to administer a topical steroid to the intricate and deep regions of the nasal cavity crucial for sinus ventilation and drainage